Participation of Clinical Pharmacist in the Treatment of One Case of Liver Injury Induced by Hepatitis B Virus Reactivation Caused by Chemotherapy
- VernacularTitle:临床药师参与1例化疗药物致乙肝病毒再激活病例的治疗
- Author:
Yingjie SU
;
Min CUI
;
Xiaoyan LIU
;
Chi ZHANG
- Publication Type:Journal Article
- Keywords:
Clinical pharmacists;
Hepatitis B virus reactivation;
Liver injury
- From:
China Pharmacist
2016;19(7):1309-1310,1311
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the participation ways of clinical pharmacists in clinical drug treatment to improve the rationality of drug use through the involvement in the drug treatment of patients with liver injury induced by hepatitis B virus reactivation caused by chemotherapy .Methods:Clinical pharmacists provided advice on drug use in accordance with evidence -based medicine , developed in-dividualized treatment program with clinicians and promoted clinical rational drug use .Results:Clinical pharmacist gave advice to cli-nicians based on the causes of liver function damage , hepatoprotective and anti HBV drug selection and evidence-based medicine , and the liver function of the patient was recovered rapidly .Conclusion:Clinical pharmacists can provide pharmaceutical service , partici-pate in individualized treatment of cancer patients , avoid delay of effective drug treatment , and effectively improve drug treatment level and medical quality .
